We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LWAC:NASDAQLightWave Acquisition Corp. Analysis

Data as of 2026-05-22 - not real-time

$10.20

Latest Price

8/10Risk

Risk Level: High

Executive Summary

LWAC trades at $10.20, just above its 20‑day SMA of $10.19 and the 200‑day SMA of $10.08, indicating a modest bullish bias. Technicals show a bullish MACD crossover (MACD line $0.0046 above signal $0.0041) and an RSI of 59, suggesting room for upside without being overbought. However, volume has been decreasing and daily volume sits at a mere 5 shares, flagging significant liquidity concerns.
Fundamentally, the company reports zero revenue, negative book value per share (-$0.876) and a price‑to‑book ratio of -11.6, which points to an overvalued valuation relative to its assets. Cash on hand is only $625k against a market cap of $306.8 M, and operating cash flow is negative, underscoring a weak financial foundation. The SPAC structure adds sector‑specific risk, and the beta near zero combined with a low 30‑day volatility of 1.9 % masks the underlying business uncertainty. No dividend is paid, confirming the lack of sustainable income for investors. In the current “Extreme Greed” market sentiment environment, speculative interest may support short‑term price moves, but the absence of a merger target keeps long‑term prospects ambiguous. The support level sits at $10.16, just below the current price, while resistance at $10.20 may cap immediate gains. Any announcement of a definitive business combination would be the primary catalyst to justify the current price level.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and price above short‑term SMA
  • Decreasing volume and very low daily liquidity
  • Support level just below current price

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Zero revenue and negative book value
  • No clear merger target increasing SPAC uncertainty
  • Overvalued price‑to‑book ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential upside if a merger is announced
  • Sector exposure to SPAC regulatory scrutiny
  • Current market sentiment of extreme greed may sustain speculative interest

Key Metrics & Analysis

Financial Health

P/B Ratio-11.6
Op. Cash Flow$-520284
Industry P/E16.7

Technical Analysis

TrendBullish
RSI59.1
Support$10.16
Resistance$10.20
MA 20$10.19
MA 50$10.18
MA 200$10.08
MACDBullish
VolumeDecreasing
Fear & Greed Index91.66

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta-0.01
Volatility1.91%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.